Navigation Links
Particle Sciences, Inc. and Dow Corning Corporation Cooperate to Develop New Product Technology
Date:10/6/2009

BETHLEHEM, Pa., Oct. 6 /PRNewswire/ -- Particle Sciences has announced today that they have been engaged by Dow Corning to develop technology for a key Dow Corning product development project. Bruce Frank, Director of Project Management for Particle Sciences remarked, "This is a little outside our normal focus of pharmaceutical development but the technological approach is perfectly analogous. We expect to provide a novel and robust solution that allows Dow Corning to develop a product that will benefit its customers." Andrew Loxley, Director, New Technologies for Particle Sciences added that "Particle Sciences is leveraging its extensive experience and expertise to evaluate a number of technologies deemed suitable for the complex performance characteristics of this particular product. Developing a suitable approach will lead directly to a fast-track scale-up and technology transfer program to commercialize this product." Additional terms of the agreement have not been released.

About Dow Corning

Dow Corning Corporation provides performance-enhancing solutions to serve the diverse needs of more than 25,000 customers worldwide. A global leader in silicones, silicon-based technology and innovation, Dow Corning offers more than 7,000 products and services via the company's Dow Corning(®) and XIAMETER(®) brands. Dow Corning is a joint venture equally owned by The Dow Chemical Company and Corning, Incorporated. More than half of Dow Corning's annual sales are outside the United States.

About Particle Sciences

Particle Sciences is a Bethlehem, PA based Contract Formulation and Analytical Services company that focuses on the Pharmaceutical Industry. Their services include the development of novel encapsulation and drug delivery technologies including drug-device combination products, nanoparticle production and characterization, cGMP analytical services and clinical drug product manufacturing for Phase I and II clinical trials. Visit www.particlesciences.com, email info@particlesciences.com or contact us at (610) 861-4701 for information.

    Maureen Cochran 610-861-4701

SOURCE Particle Sciences


'/>"/>
SOURCE Particle Sciences
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. New CapSure™ Cleanroom Wiper from Berkshire Corporation Captures and Retains 42 Times More Contaminant Particles
2. Engineers produce how-to guide for controlling the structure of nanoparticles
3. New discovery reveals fate of nanoparticles in human cells
4. NOVAVAX Announces Positive Results for the Second Phase II Clinical Trial of its Trivalent Seasonal Influenza Virus-like Particle (VLP) Vaccine Candidate
5. Bio-enabled, surface-mediated approach produces nanoparticle composites
6. NOVAVAX Virus-Like Particle Vaccine Protects Against 2009 Pandemic H1N1 Influenza Virus
7. Capping a two-faced particle gives duke engineers complete control
8. Nanotech particles affect brain development in mice
9. Particle Sciences and Microfluidics Collaborate to Share Formulation and Nanotechnology Expertise for Pharmaceutical Drug Product Development, Analysis and Commercialization
10. Preclinical Proof-of-Concept Studies Published for Novavax Seasonal Influenza Virus-Like-Particle Vaccine
11. Novavax and the NIH Agree to Evaluate a Virus-like Particle (VLP) Vaccine Candidate Against the Novel Influenza A (H1N1) Virus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... ... June 23, 2016 , ... ClinCapture, the ... Convention Center and will showcase its product’s latest features from June 26 to ... a scientific poster on Disrupting Clinical Trials in The Cloud during the conference. ...
(Date:6/23/2016)... ... June 23, 2016 , ... Velocity ... intelligent tools designed, tuned and optimized exclusively for Okuma CNC machining centers at ... result of a collaboration among several companies with expertise in toolholding, cutting tools, ...
(Date:6/23/2016)... India , June 23, 2016 ... media market research report to its pharmaceuticals section ... profiles, product details and much more. ... spread across 151 pages, profiling 15 companies and ... available at http://www.reportsnreports.com/reports/601420-global-cell-culture-media-industry-2016-market-research-report.html . ...
(Date:6/22/2016)... , June 22, 2016 Research and ... Global Markets" report to their offering. ... billion in 2014 from $29.3 billion in 2013. The market is ... of 13.8% from 2015 to 2020, increasing from $50.6 billion in ... projected product forecasts during the forecast period (2015 to 2020) are ...
Breaking Biology Technology:
(Date:4/13/2016)... , April 13, 2016  IMPOWER physicians supporting ... are setting a new clinical standard in telehealth thanks ... By leveraging the higi platform, IMPOWER patients can routinely ... pulse and body mass index, and, when they opt ... and convenient visit to a local retail location at ...
(Date:3/31/2016)... , March 31, 2016  Genomics firm Nabsys has ... CEO, Barrett Bready , M.D., who returned to ... the original technical leadership team, including Chief Technology Officer, ... Product Development, Steve Nurnberg and Vice President of Software ... the company. Dr. Bready served as CEO ...
(Date:3/23/2016)... WAKEFIELD, Massachusetts , March 23, 2016 ... kombiniert im Interesse erhöhter Sicherheit Gesichts- und ... Xura, Inc. (NASDAQ: MESG ... heute bekannt, dass das Unternehmen mit SpeechPro ... insbesondere aus der Finanzdienstleistungsbranche, wird die Möglichkeit ...
Breaking Biology News(10 mins):